Skip Ribbon Commands
Skip to main content

Title

MSM at Highest Risk for HIV Acquisition Express Greatest Interest and Preference for Injectable Antiretroviral PrEP Compared to Daily, Oral Medication.

Authors

KB Biello, MJ Mimiaga, Cm Santostefano, et al.;

Network Affiliation

Other

Organization

 

Journal Name

AIDS and Behavior

Publication Date

11/8/2017

PubMed Search

https://www.ncbi.nlm.nih.gov/pubmed/29119472

Link to full-text

 

PMID

29119472

Abstract

​Men who have sex with men (MSM) account for nearly 70% of new HIV diagnoses, with young black MSM at the highest risk for infection in the United States. Pre-exposure prophylaxis (PrEP) can decrease HIV acquisition in at-risk individuals by over 90%. However, therapeutic efficacy requires a daily pill, posing adherence challenges. Experimental modalities, including injectable PrEP given once every 2 months, may improve adherence among those most in need. To assess interest in and preference for injectable PrEP, an online survey was mounted on two popular MSM sexual networking apps. Differences by age, race, and other characteristics were examined using multinomial logistic regressions. Of 4638 respondents, 73% expressed interest in injectable PrEP and 47% indicated they would prefer an injection (compared to 17% who prefer a daily pill and 36% who were unsure). Within this sample, interest in and preference for injectable PrEP was highest among MSM at highest risk for HIV infection (i.e., younger age groups, racial/ethnic minorities, those with risker sexual behavior). As a result, if proven effective in clinical trials, injectable PrEP has the potential to reduce social disparities in HIV transmission among MSM.

Keywords

 

Topic

Adherence; Adolescents/Youth; Behavior; Black; MSM; Racial Disparities

Attachments

Created at 11/13/2017 2:42 PM by Davis, Gregory P
Last modified at 11/13/2017 2:42 PM by Davis, Gregory P